Jamie Cesanek

In recent trial results, a dose reduction of Xpovio (selinexor) was associated with longer progression-free survival and duration of response while also reducing side effects in patients with multiple myeloma.

From the death of Nick Cannon’s five-month-old son due to brain cancer to the late-stage diagnosis of Kansas City reporter Matt Stewart’s wife, here’s what’s happening in the cancer landscape this week.

On this episode of the “Cancer Horizons” podcast, a woman with multiple myeloma shares how she made the best of her cancer treatment process by channeling her emotions through fashion expression.

People who have successfully navigated difficult times in the past may be able to use those previous coping strategies to help them weather new stress related to a cancer diagnosis, treatment or survivorship, according to an expert from the George Washington University Cancer Center.

From Kathy Griffin sharing that she is now cancer free to Michael Bublé discussing his son’s cancer journey, here’s what’s happening in the cancer landscape this week.

Investigators plan to analyze the safety and efficacy of a novel cancer therapy for the treatment of patients with RAF-altered solid tumors.

On this episode of the “Cancer Horizons” podcast, a man explains how his late wife’s breast cancer diagnosis changed his life and his understanding of the disease.

The first patient was randomized in the phase 2 trial examining Tedopi and Opdivo for non-small cell lung cancer.

Several CURE® Calendar Contest winners describe their winning creations and discuss how they used art as a medium of coping with the struggles of cancer.

Part B of the DIONE-01 study will look at whether IOA-244 increases anti-tumor responses in expansion groups of patients.

From Dick Vitale’s return to sportscasting after a brief pause for cancer treatment to a cancer survivor walking 3,000 miles cross-country, here’s what’s happening in the cancer landscape this week.

CURE® recently asked its readers on social media to share who or what they were most thankful for having during their cancer experience. Here’s what they had to say.

By understanding family history, an individual can better reveal their genetic breast cancer risk and whether or not they are a candidate for genetic testing.

On this episode of the “Cancer Horizons” podcast, an expert from the Huntsman Cancer Institute explains how physical exercise can help patients with cancer and potentially reduce side effects.

Several CURE® Calendar Contest winners explain the stories behind their winning artwork and how their artmaking helped them through the difficulties of cancer.

From Taylor Swift’s heartfelt tribute to a 4-year-old boy who died from cancer to Senator Amy Klobuchar’s announcement that she is cancer-free, here’s what’s happening in the cancer landscape this week.

On this episode of the “Cancer Horizons” podcast, actress and comedian Jessica St. Clair and writer Dan O’Brien share their cancer stories and how they channeled their emotions through creativity.

A phase 2 trial of aspacytarabine (BST-236) was initiated in patients with AML and MDS.

An expert explains what treatment strategies are available for patients with metastatic breast cancer, how far research has come and why patients shouldn’t lose hope.

The TRANSCEND CLL 004 trial is currently enrolling patients to determine the efficacy of a CAR-T cell therapy.

The first patient with bladder cancer was dosed in a phase 1/2 trial examining responses to an investigational immunotherapy.

The Food and Drug Administration granted approval to Besremi for the treatment of adults with polycythemia vera.

From the death of Frederik Willem de Klerk to study results showing palm oil contains an acid that may cause cancer spread, here’s what’s happening in the cancer landscape this week.

The first patient has been enrolled in the APOLLO 613 Phase 1/2 clinical trial for CPI-613.

On this episode of the “Cancer Horizons” podcast, a young mother living with lung cancer shares the story of her cancer diagnosis and describes the once-in-a-lifetime coincidence of learning her neighbor has the same cancer type and mutation.

A phase 1 trial of ONO-4685 was initiated for the evaluation of the antibody in patients with relapsed or refractory t-cell lymphoma.

From the deaths of Jovita Moore and Jerry Remy due to cancer, to Boyd Huppert’s myeloma diagnosis, here’s what’s happening in the cancer landscape this week.

The first patients were dosed in a phase 2 trial for a topical gel to treat lesions in patients with colorectal cancer receiving EGFR inhibitor therapy.

An expert explains the various treatment options available for a patient who is diagnosed with a small renal mass.

From the death of “Friends” actor James Michael Tyler to Sally Yates’ breast cancer announcement, here’s what’s happening in the cancer landscape this week.